These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1189590)

  • 1. The effect of the sclerosing agent "hydroxypolyaetoxydodecan" on the coagulation potentials: in vitro investigations.
    Wuppermann T; Haas KH
    Vasa; 1975; 4(1):45-53. PubMed ID: 1189590
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro effects of detergent sclerosants on clot formation and fibrinolysis.
    Parsi K; Exner T; Low J; Fung Ma DD; Joseph JE
    Eur J Vasc Endovasc Surg; 2011 Feb; 41(2):267-77. PubMed ID: 21183368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of various sclerosing solutions on blood coagulation parameters in vitro and in patients during sclerosing of varicose veins].
    Brenn H; Imhoff E; Duckert F
    Vasa; 1976; 5(3):199-202. PubMed ID: 969844
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles.
    Parsi K; Exner T; Connor DE; Ma DD; Joseph JE
    Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):731-40. PubMed ID: 17919946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: possible additional mechanism of adverse reaction during sclerotherapy.
    Cacciola E; Giustolisi R; Musso R; Vecchio R; Longo A; Triolo A; Cacciola RR
    J Lab Clin Med; 1987 Feb; 109(2):225-6. PubMed ID: 3805873
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mechanism of action, indications and problems in using aethoxysklerol as a sclerosing agent in esophageal varices].
    Nishimura S; Yoshida T; Okita K
    Nihon Rinsho; 1990 Apr; 48(4):718-21. PubMed ID: 2366358
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro effects of detergent sclerosants on antithrombotic mechanisms.
    Parsi K; Exner T; Low J; Ma DD; Joseph JE
    Eur J Vasc Endovasc Surg; 2009 Aug; 38(2):220-8. PubMed ID: 19442540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of detergent sclerosants on fibrinolytic enzymes and inhibitors.
    Parsi K; Exner T; Ma DD; Joseph JE
    Thromb Res; 2010 Oct; 126(4):328-36. PubMed ID: 20682454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of polidocanol as a constituent of a venous sclerosing agent on cardiac electrical activity. Studies on the isolated perfused heart and papillary muscle of the guinea pig and on the isolated sinus node of the rabbit.
    Oexle B; Weirich J; Haverkampf K; Antoni H
    Arzneimittelforschung; 1988 Nov; 38(11):1578-82. PubMed ID: 3214440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sodium tetradecyl sulfate as a sclerosing solution in the therapy of esophageal varices].
    Ohashi M; Iwase H; Horiguchi H; Nakane M; Nagata J
    Nihon Rinsho; 1990 Apr; 48(4):722-6. PubMed ID: 2366359
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the coagulation and fibrinolysis in varicose blood before and after the injection of sclerosing solutions].
    Ludwig H
    Med Welt; 1967 Feb; 7():379-81. PubMed ID: 6045239
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of histology findings and isotope scanning in thrombi due to sclerosing solutions].
    Echtermeyer V; Wuppermann T
    Vasa; 1979; 8(3):217-20. PubMed ID: 516860
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the sclerotherapeutic efficacy of ethanol, polidocanol, and OK-432 using an in vitro model.
    Mol W; Furukawa H; Sasaki S; Tomaru U; Hayashi T; Saito A; Nagao M; Saito N; Hata S; Yamamoto Y
    Dermatol Surg; 2007 Dec; 33(12):1452-9. PubMed ID: 18076610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyethylene glycol 6,000 enhancement of the clotting of fibrinogen solutions in visual and mechanical assays.
    Fenton JW; Fasco MJ
    Thromb Res; 1974 Jun; 4(6):809-17. PubMed ID: 4858454
    [No Abstract]   [Full Text] [Related]  

  • 15. Coagulation parameters after sclerotherapy.
    Baele G; De Vos M; Hublé F; Van Eeghem P; Elewaut A; Barbier F
    Endoscopy; 1986 Jul; 18(4):168. PubMed ID: 3488207
    [No Abstract]   [Full Text] [Related]  

  • 16. The efficacy of polidocanol in pleurodesis in rats.
    Cetin B; Koçkaya EA; Atalay C; Akay MT; Cetin A
    Surg Today; 2003; 33(9):688-92. PubMed ID: 12928847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of local sclerosing agents on hemostasis of hepatic bleeding.
    Aysan E; Basak F; Kinaci E; Tutuncu H
    Hepatogastroenterology; 2007 Jun; 54(76):1212-5. PubMed ID: 17629072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An error too widely spread among the public, even among medical personnel: the risk of hypercoagulation caused by sclerosing solutions].
    Tournay R
    Phlebologie; 1977; 30(2):161-3. PubMed ID: 905335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [State of the coagulation system of the blood following treatment of varicose enlargment of the veins of the lower extremity with phlebosclerosing preparations].
    Liul'ka AN; Pereĭma FA; Berezovskiĭ OI
    Vestn Khir Im I I Grek; 1975 Apr; 114(4):15-8. PubMed ID: 1224506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative stability of sodium tetradecyl sulphate (STD) and polidocanol foam: impact on vein damage in an in-vitro model.
    McAree B; Ikponmwosa A; Brockbank K; Abbott C; Homer-Vanniasinkam S; Gough MJ
    Eur J Vasc Endovasc Surg; 2012 Jun; 43(6):721-5. PubMed ID: 22507925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.